drugset / Trial / NCT00525993
Efficacy and Safety of Etoricoxib in Acute Ankle Sprain: A Double-Blind Comparative Study Among 2 Treatments Protocols
Phase 4
Unknown
50 enrolled
Núcleo de Estudos em Esportes e Ortopedia, Brazil
Merck Sharp & Dohme LLC · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The investigators will study 2 doses of etoricoxib to prove that 60 mg once daily will be non-inferior to etoricoxib 90mg daily (for 14 days) in the treatment of acute ankle sprain in sports. The investigators objective is to discuss the point that the investigators will follow the minimal dose that is effective for the treatment of this acute condition in orthopedic.
Timeline
- Start
- 2008-12
- Primary completion
- 2009-08
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Etoricoxib | Small molecule | 60 mg | Oral |
| Comparator | Etoricoxib | Small molecule | 90 mg | Oral |
Indications
No indication recorded.